Regeneron Pharmaceuticals. (REGN), Sanofi Win Approval of Zaltrap for Colon Cancer - Bloomberg

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. SPY
3. DOO
4. HD
5. ARGX
6. AMLX
7. KLAR
8. METC
9. FN
10. XP

Go back to Regeneron Pharmaceuticals. (REGN), Sanofi Win Approval of Zaltrap for Colon Cancer - Bloomberg
Regeneron (NASDAQ: REGN) Delayed: 815.23 +9.30 (1.15%)
Previous Close $805.93    52 Week High $592.36 
Open $814.00    52 Week Low $325.35 
Day High $821.02    P/E 213.97 
Day Low $805.93    EPS $3.81 
Volume 340,743